Clinical Laserthermia Systems AB (publ)

Research Clinical Laserthermia Systems AB (publ) (LS60) on Bullrun: market cap EUR 3.68M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 3.68M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025SEK 17.49M-SEK 41.61M-SEK 36.00M62.4%-1.66SEK 21.55MSEK 224.00KSEK 69.67M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24EUR 3.68Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Clinical Laserthermia Systems AB (publ)'s market cap?

Clinical Laserthermia Systems AB (publ)'s market capitalization is EUR 3.68M.

What does Clinical Laserthermia Systems AB (publ) do?

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices.